REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $31,000 | -42.6% | 156,179 | +89.4% | 0.00% | -42.9% |
| Q2 2018 | $54,000 | -50.5% | 82,455 | -46.0% | 0.01% | -50.0% |
| Q1 2018 | $109,000 | -39.4% | 152,559 | -12.0% | 0.01% | -36.4% |
| Q4 2017 | $180,000 | -19.6% | 173,295 | -3.4% | 0.02% | -24.1% |
| Q3 2017 | $224,000 | +13.7% | 179,321 | -10.1% | 0.03% | +11.5% |
| Q2 2017 | $197,000 | -34.1% | 199,521 | +10.3% | 0.03% | -36.6% |
| Q1 2017 | $299,000 | +51.8% | 180,921 | +106.8% | 0.04% | +41.4% |
| Q4 2016 | $197,000 | +84.1% | 87,501 | +170.0% | 0.03% | +81.2% |
| Q3 2016 | $107,000 | -21.3% | 32,411 | -31.1% | 0.02% | -27.3% |
| Q2 2016 | $136,000 | -40.1% | 47,061 | +43.4% | 0.02% | -43.6% |
| Q1 2016 | $227,000 | -26.1% | 32,815 | -6.8% | 0.04% | -29.1% |
| Q4 2015 | $307,000 | -45.6% | 35,215 | -59.2% | 0.06% | -51.3% |
| Q3 2015 | $564,000 | -44.8% | 86,295 | -7.4% | 0.11% | -39.9% |
| Q2 2015 | $1,021,000 | +30.4% | 93,165 | +101.6% | 0.19% | +41.4% |
| Q1 2015 | $783,000 | – | 46,205 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|